Last reviewed · How we verify
NCT05593861
Assessment of Enhanced Recovery After Surgery Implementation at Pediatric Surgery Practices in Mainland China
trial in ERAS in 66 participants. Completed in 21 July 2022.
1 July 2022
Quick facts
| Lead sponsor | Weibing Tang |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 66 |
| Start date | 1 July 2021 |
| Primary completion | 1 July 2022 |
| Estimated completion | 21 July 2022 |
| Sites | 1 location across China |
Conditions studied
- ERAS — all drugs for ERAS →
Sponsor
Weibing Tang
Who can join
Eligibility, any sex, with ERAS. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Enhanced recovery after surgery (ERAS) is a new mode to optimize perioperative management, the core of which is to reduce perioperative physiological and psychological trauma and stress damage, and accelerate postoperative rehabilitation. ERAS has been gradually introduced in pediatric surgery in recent years, however, there are limited reports on its overall implementation. We aimed to determine the popularity of ERAS among pediatric populations in mainland China.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05593861
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for ERAS
Currently open trials in the same condition.
- NCT07276126 — The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlle · NA · recruiting
- NCT07210164 — Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study · NA · recruiting
- NCT07116564 — Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries · Phase 4 · recruiting
- NCT07087366 — Enhanced Recovery After Surgery(ERAS) Following Gynaecological Oncology Surgery in a Tertiary Level Hospital · NA · recruiting
- NCT06786819 — Impact of a Technology Platform Based on Enhanced Recovery After(ERAS) Surgery on Length of Stay After Coronary Artery B · NA · recruiting
Other Weibing Tang trials
Trials by the same sponsor.
- NCT05655845 — Risk Factors for Bowel Dysfunction at Preschool and Early Childhood Age in Children With Hirschsprung Disease · unknown
- NCT05461924 — The Long Term Outcomes After Pull-through of Long Segment Hirschsprung Disease · unknown
- NCT04464057 — Safety and Effectiveness of Early Feeding After Bowel Anastomosis in Neonates or Infants · NA · completed
- NCT05909033 — Early Predictors for the Short Term Native Liver Survival in Patients With Biliary Atresia After Kasai Procedure · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05593861 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Weibing Tang
- Last refreshed: 25 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05593861.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing